Saroja Pharma Industries India Ltd. Stock Analysis SAROJA.NS

Saroja Pharma Industries India Ltd. is a pharmaceutical and healthcare company, which business includes Pharmaceuticals Ingredients, Specialty Chemicals, Intermediates for Pharma trading, and into specialty chemicals imports and exports as well as supply. The company employs 12 full-time employees The company went IPO on 2023-09-13. The firm operates as a trader, exporter and supplier of specialty chemicals. The company offers pharma active pharmaceutical ingredient (API) products which include Closantel Sodium Dihydrate, Furosemide, Oxfendazole, Rafoxanide, Trichlorocarbanilide (TCC), Clorsulon, Diethyl Carbamazine, Niclosamide, Pyrantel Pamoate, and Povidone lodine. The company also offers pharma intermediates which include Intermediates for Amoxapine & Loxapine, Methyl-3-Amino-2-Thiophene Carboxy, Intermediates for Tiotropium Bromide, Intermediates for Suxamethonium, Intermediates for Brinzolamide, Intermediates for Lornoxicam, Intermediates for Linezolid, Intermediates for Glimepiride, Intermediates for Gefitinib, and Intermediates for Ezetimibe. The company also offers Aluminium Chloride Anhydrous Powder, Triethylamine Hydrochloride, Potassium Carbonate Granules, Sodium Hydro Sulphide, Tetra Butyl Ammonium Bromide, and Chlorosulphonic Acid.